Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis
NCT01486524
·
clinicaltrials.gov ↗
UNKNOWN
Status
3000
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Sepsis
Septic Shock
Sponsor
Sirius Genomics Inc.